Delivery Order SPE2DB20D3103-SPE2DB25FL5G6

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $9.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,633.98, is for the delivery of 4562910313 - FLUORESCEIN SODIUM 10% VIAL 5ML. This is a Firm Fixed Price Delivery Order contract with a completion date of November 28, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of 5 mL vials of 10% Fluorescein Sodium, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,066.33, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 4, 2024. The contract is a Firm Fixed Price Delivery Order with a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,453.47 and an ultimate completion date of November 18, 2024. It is for the procurement of Fluorescite 10% vial, 5mL, a medical product used in ophthalmology. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating open competition....
This federal contract award, with an ID of SPE2DB22D3301|SPE2DB24FX4TW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluorescein Sodium 10% Vial 5ml, a medical product, with a total ceiling value of $44,022.85. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and the ultimate completion date is November 2, 2023....
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,249.68 firm fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,627.38 Firm-Fixed-Price Delivery Order contract has a completion date of June 11, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,128.78 firm fixed-price delivery order contract covers a range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, eye drops, creams, tablets, capsules, injectable medications, and vaccines...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,771.72 firm fixed-price delivery order contract has a completion date of June 3, 2024 and is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,545.53 firm fixed-price delivery order contract has a completion date of November 12, 2024, and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,149.06 Firm Fixed Price Delivery Order contract is for the supply of 4566634213 - DEV VSCSRG VISCOAT OPTH 4% CHONDROITIN, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL5G6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,370.60 firm fixed-price delivery order is for the supply of fluorescein sodium 10% vials, a common ophthalmic medication, with a completion date of November 4, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:51 AM